Organisers of CPHI North America which takes place this year at Pennsylvania Convention Center in Philadelphia 7-9 May, say they expect to see a doubling of attendees* from Purchasing and Procurement’, R&D and Manufacturing, and ‘QC and QA’ pharma testing sectors. Informa says it attributes this expected rapid increase to both a concerted effect to attract larger buying audiences, but also due to a response by the USA industry to macro trends – with alternative supply chains options actively being sought by both pharma and biotech companies.
“We have spent a good deal of time researching and investing resources to target these audiences in the last 12 months – in response to exhibitor feedback – but it also shows the strong desire we see among US-based companies to seek out alternative supply options and new partners. Our role is to actively help facilitate these discussions and build an ecosystem of much larger networking opportunities at the event. Companies across the industry have taken note of developments that might affect supply – particularly among the largest CDMOs (contract development and manufacturing organisations) – and we are here to help them navigate their options and find new suppliers,” said Sarah Griffin, manager, pharma brand US at Informa Markets.
Informa said it has over 350 exhibitors contracted and has added three new engagement zones – covering sustainability, innovation, and growth & development – alongside the first ever Start-Up Market in North America, a dedicated space where smaller innovators and enterprises from the industry can exhibit their exciting new products and solutions.
“CPHI remains at the heart of pharma in North America, and we love that we’re attracting an increasing number of industry leaders. We are seeing rising numbers of new attendees, particularly this year as we see senior executives from R&D, QC and manufacturing audiences specifically looking to re-evaluate both supply and development options,” said Adam Andersen, Informa’s executive vice-president, Pharma. He added “The great thing about CPHI North America is that we’re still the only show bringing the entire US pharma supply chain together under one roof - in person, and thanks to our online event platforms our attendees and exhibitors are already making new connections ahead of the event and actively taking forward discussion to forge crucial supply chain partnerships.”
This year’s conference features four tracks – spanning ‘Sustainable Futures’, ‘Revolutionizing Drug Manufacturing’, ‘Supply Chain Economy’, and ‘Exploring Excipients’ – as well as a breakfast session on manufacturing excellence and the CDMO roundtable. The latter is particularly timely, with US based manufacturers in high demand in 2024. In total CPHI North American features 50+ experts spanning dozens of sessions that encompass the entire pharmaceutical development and supply chain, with seminars covering themes as varied as ‘marketing’, ‘diversity’ and ‘wellbeing’.
Additionally, in a sign of pharma’s increased social responsibility, the new sustainability zone will also host a ‘commitments communication area’: where companies go to publicly pledge their goals and targets for environmental, sustainability or governance over the next few years.
To find out more about this year’s networking, the new personalised options and registration badges, please visit CPHI North America.
